Clarity Pharmaceuticals Ltd

Clarity Pharmaceuticals Ltdverified

CU6.AX

Price:

$3.09

Market Cap:

$1.15B

Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, develops theranostic therapy and imaging products for the treatment of cancer in children and adults. Its lead product includes SARTATE, a targeted theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express somatostatin receptor 2. The company is also developing SAR-Bombesin, a pan cancer theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express gastrin releasing peptide receptor; and SAR-bisPSMA, a theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express prostate specific membrane antigen. The company has...[Read more]

Industry

Biotechnology

IPO Date

2021-08-25

Stock Exchange

ASX

Ticker

CU6.AX

The Current Ratio as of December 2025 (TTM) for Clarity Pharmaceuticals Ltd (CU6.AX) is 9.69

According to Clarity Pharmaceuticals Ltd’s latest financial reports and current stock price. The company's current Current Ratio is 9.69. This represents a change of -29.58% compared to the average of 13.76 of the last 4 quarters.

Clarity Pharmaceuticals Ltd (CU6.AX) Historical Current Ratio (quarterly & annually)

How has CU6.AX Current Ratio performed in the past?

The mean historical Current Ratio of Clarity Pharmaceuticals Ltd over the last ten years is 10.50. The current 9.69 Current Ratio has changed 9.13% with respect to the historical average. Over the past ten years (40 quarters), CU6.AX's Current Ratio was at its highest in in the December 2020 quarter at 58.83. The Current Ratio was at its lowest in in the December 2017 quarter at 0.

Quarterly (TTM)
Annual

Average

10.50

Median

9.85

Minimum

3.18

Maximum

19.05

Clarity Pharmaceuticals Ltd (CU6.AX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Clarity Pharmaceuticals Ltd Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 186.42%

Maximum Annual Current Ratio = 19.05

Minimum Annual Increase = -49.11%

Minimum Annual Current Ratio = 3.18

Quarterly (TTM)
Annual
YearCurrent RatioChange
20259.69-49.11%
202419.0587.34%
202310.17-23.34%
202213.2632.61%
202110.004.60%
20209.565.04%
20199.10186.42%

Clarity Pharmaceuticals Ltd (CU6.AX) Average Current Ratio

How has CU6.AX Current Ratio performed in the past?

The current Current Ratio of Clarity Pharmaceuticals Ltd (CU6.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

12.97

5-year avg

12.43

10-year avg

10.50

Clarity Pharmaceuticals Ltd (CU6.AX) Current Ratio vs. Peers

How is CU6.AX’s Current Ratio compared to its peers?

Clarity Pharmaceuticals Ltd’s Current Ratio is less than Neuren Pharmaceuticals Limited (40.42), less than PYC Therapeutics Limited (14.41), greater than Dimerix Limited (3.26), greater than Mesoblast Limited (1.99), greater than Regis Healthcare Limited (0.11), greater than Orthocell Limited (4.97), less than Immutep Limited (11.69), greater than Nanosonics Limited (5.66), less than Island Pharmaceuticals Limited (22.27), greater than Clinuvel Pharmaceuticals Limited (9.66),

Build a custom stock screener for Clarity Pharmaceuticals Ltd (CU6.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clarity Pharmaceuticals Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clarity Pharmaceuticals Ltd (CU6.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clarity Pharmaceuticals Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Clarity Pharmaceuticals Ltd's Current Ratio?

How is the Current Ratio calculated for Clarity Pharmaceuticals Ltd (CU6.AX)?

What is the highest Current Ratio for Clarity Pharmaceuticals Ltd (CU6.AX)?

What is the 3-year average Current Ratio for Clarity Pharmaceuticals Ltd (CU6.AX)?

What is the 5-year average Current Ratio for Clarity Pharmaceuticals Ltd (CU6.AX)?

How does the current Current Ratio for Clarity Pharmaceuticals Ltd (CU6.AX) compare to its historical average?